Short answer

Since 28 May 2026, four EUDAMED modules are mandatory: actor registration, UDI/device registration, Notified Bodies and certificates, and market surveillance. Commission Decision (EU) 2025/2371, published on 27 November 2025, started the six-month transition under Regulation (EU) 2024/1860. A device placed on the EU market for the first time, including software, must be registered before it is placed on the market; devices already on the market must be registered by 28 November 2026. Manufacturers first need a Single Registration Number, issued by the competent authority after an actor registration request; non-EU manufacturers go through their authorised representative.

Why 28 May 2026 made EUDAMED mandatory

On 26 November 2025, the European Commission adopted Decision (EU) 2025/2371 confirming that four EUDAMED modules are functional; it was published in the Official Journal on 27 November 2025. Under the gradual roll-out introduced by Regulation (EU) 2024/1860, that publication triggered a six-month transition period, and use of these four modules became mandatory on 28 May 2026.

This is not a soft deadline. Since 28 May 2026, a device placed on the EU market for the first time — including software as a medical device — must be registered in EUDAMED before it is placed on the market, and devices that were already on the market have until 28 November 2026. Member States lay down the penalties for infringements of the MDR (Article 113), and competent authorities can take market surveillance measures against non-compliant devices.

Who this affects: Manufacturers, EU authorised representatives, importers and system/procedure pack producers must register as actors in EUDAMED, and manufacturers must register their devices. If your SaMD company is based outside the EU, you submit your own actor registration; your EU authorised representative verifies it, and the competent authority responsible for your authorised representative validates it and issues your SRN.

The four mandatory modules — what each one requires

Actor registration

Manufacturers, importers, authorised representatives and system/procedure pack producers must register in EUDAMED and obtain a Single Registration Number (SRN). There is no transition period for this module. The registration request is submitted in EUDAMED and validated by the relevant national competent authority, which then issues the SRN. For a non-EU manufacturer, the EU authorised representative first verifies the request, and the competent authority responsible for the authorised representative validates it.

The SRN is the foundation of everything else: you need it before you can register devices. Validation times differ between competent authorities, so if you still do not have an SRN, submit your request now.

UDI/Device registration

Devices placed on the EU market from 28 May 2026 must be registered before the first unit is placed on the market — there is no transition period for them. Devices placed on the market before 28 May 2026 that you continue to place on the market — both MDR devices and legacy devices placed on the market under the MDR's transitional provisions — must be registered no later than 28 November 2026 (12 months after the Commission's notice was published).

For software, the UDI rules are specific (MDR Annex VI, Part C, section 6.5, explained in MDCG 2018-5). The Basic UDI-DI groups versions with the same intended purpose, risk class and essential design and manufacturing characteristics. A new UDI-DI is required whenever a modification changes the original performance, the safety or the intended use of the software, or the interpretation of data — for example new or modified algorithms, database structures, operating platform, architecture, user interfaces or new channels for interoperability. Minor software revisions — bug fixes, usability enhancements that are not for safety purposes, security patches or operating efficiency — require a new UDI-PI, not a new UDI-DI. The software identification serves as the production identifier, and UDI-PI information is not entered in the EUDAMED UDI database. Every new UDI-DI, however, must be registered, so UDI decisions need to be built into your change management process.

Notified Bodies and certificates

Notified Bodies enter the information on the certificates they issue. For MDR certificates issued before 28 May 2026, NBs have until 28 May 2027 to enter the information. You still need to make sure the certificate data is accurate and linked to your device registrations — check with your NB.

Market surveillance (for authorities)

This module is used by national competent authorities and the European Commission to exchange information on market surveillance activities. Manufacturers do not report into it, and it is not the vigilance module. Serious incidents, field safety corrective actions (FSCAs), trend reports and periodic safety update reports (PSURs) belong to the separate vigilance and post-market surveillance module, which is still in development and not yet mandatory. Until it is, serious incidents and FSCAs continue to be reported to the national competent authorities, as before. Your post-market surveillance process should keep these national reporting routes and be ready to switch once the vigilance module becomes mandatory.

Your EUDAMED action checklist — by priority

  1. Check your actor registration and SRN: Without an SRN you cannot register devices. If you are a non-EU manufacturer, your request is verified by your EU authorised representative and validated by the competent authority responsible for it; EU manufacturers are validated by the competent authority of their own Member State.
  2. Audit your device portfolio: List every SaMD you place on the EU market, its Basic UDI-DI and UDI-DI(s), and which software versions required a new UDI-DI.
  3. Assign UDIs if not already done: Work with an EU-designated issuing entity (GS1, HIBCC, ICCBBA or IFA) to assign Basic UDI-DIs and UDI-DIs and to define how the UDI is shown for your software.
  4. Register your devices in EUDAMED: Devices already on the market before 28 May 2026 that you continue to place on the market must be registered by 28 November 2026; any new device or new UDI-DI must be registered before it is placed on the market. Make sure your NB certificates are correctly linked.
  5. Update your QMS and change control: Add a UDI-DI assessment and the EUDAMED registration step to your software release and change control procedures, keep national vigilance reporting routes in your vigilance SOP, and track when the vigilance module becomes mandatory. If you do not have a regulatory lead in-house, part-time QA/RA support after launch can keep registrations and reporting current.
  6. Brief your EU authorised representative: If you use an EU authorised representative, confirm that it is registered as an actor, has verified your registration, and knows which devices you are registering.
What comes next: The vigilance and post-market surveillance module and the clinical investigations and performance studies module are not yet mandatory; the Commission lists them as under development. Its EUDAMED timeline (November 2025) indicates mandatory use of the vigilance module in Q2 2027, noting that this may change depending on audit results. Under Regulation (EU) 2024/1860, a module becomes mandatory six months after the Commission publishes a notice confirming its functionality in the Official Journal — so there will be advance notice. We publish regulatory updates as they are confirmed.

Common mistakes SaMD companies make with EUDAMED

Waiting for the NB to handle everything. Your Notified Body enters certificate data, but actor registration and device registration, including UDI data, are your responsibility. Don't assume your NB will do it.

Confusing a new UDI-DI with a new UDI-PI. For software, a change to performance, safety, intended use or interpretation of data needs a new UDI-DI, which must be registered in EUDAMED. Minor revisions get a new UDI-PI, which is not entered in the UDI database. Decide which applies for every release and document the rationale.

Treating the SRN as a formality. The SRN request is submitted in EUDAMED but has to be validated by a competent authority — and, for non-EU manufacturers, verified by the authorised representative first. Some authorities validate quickly; others take longer. Without the SRN, device registration cannot start.

Forgetting devices already on the market. EUDAMED registration is not just for new devices — devices placed on the market before 28 May 2026 that you continue to place on the market must be registered by 28 November 2026. Many companies focus on new product launches and overlook their existing portfolio.

How EUDAMED fits into the wider regulatory picture

EUDAMED's mandatory use is one of several developments affecting medical device software in the EU. For AI systems that are, or are safety components of, medical devices requiring Notified Body assessment, the EU AI Act's high-risk requirements now apply from 2 August 2028, after Regulation (EU) 2026/1744 moved the original August 2027 date. Notified Body capacity remains a planning factor for certification timelines, and the Commission's December 2025 proposal to simplify the MDR and IVDR is still going through the legislative process.

For SaMD companies, the practical lesson is to treat EUDAMED as part of the QMS rather than a one-off project: registrations must stay accurate with every release that needs a new UDI-DI and every certificate change, and the vigilance module will add reporting obligations once it becomes mandatory.

Official sources & references